A Study of MRI T1 Weighted Baseline Image Contrast in the Brain

Overview

About this study

In the past data has indicated that Gadolinium based contrast may specify brain tissue intensity in subsequent MRI exams. This study is being conducted to try and determine normal ranges of specific tissue ratios for old and new 1.5 and 3T systems. We are hoping that this study allows us to develop a normal range intensity/ratio profiles for specific tissue regions of interest in the brain.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Healthy adult >18 years of age that have had no prior Gadolinium contrast MRI exams.

Exclusion Criteria:

Volunteers > 18 years of age you have had previous MRI exams that included Gadolinium contrast.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Laurence Eckel, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Laurence Eckel, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials